Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy

Prasanth N Surampudi, Christina Wang, Ronald Swerdloff

Research output: Contribution to journalReview article

72 Citations (Scopus)

Abstract

Hypogonadism in older men is a syndrome characterized by low serum testosterone levels and clinical symptoms often seen in hypogonadal men of younger age. These symptoms include decreased libido, erectile dysfunction, decreased vitality, decreased muscle mass, increased adiposity, depressed mood, osteopenia, and osteoporosis. Hypogonadism is a common disorder in aging men with a significant percentage of men over 60 years of age having serum testosterone levels below the lower limits of young male adults. There are a variety of testosterone formulations available for treatment of hypogonadism. Data from many small studies indicate that testosterone therapy offers several potential benefits to older hypogonadal men. A large multicenter NIH supported double blind, placebo controlled study is ongoing, and this study should greatly enhance the information available on efficacy and side effects of treatment. While safety data is available across many age groups, there are still unresolved concerns associated with testosterone therapy. We have reviewed the diagnostic methods as well as benefits and risks of testosterone replacement therapy for hypogonadism in aging men.

Original languageEnglish (US)
Article number625434
JournalInternational Journal of Endocrinology
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Hypogonadism
Testosterone
Therapeutics
Libido
Metabolic Bone Diseases
Adiposity
Erectile Dysfunction
Serum
Osteoporosis
Young Adult
Age Groups
Placebos
Safety
Muscles

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems

Cite this

Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. / Surampudi, Prasanth N; Wang, Christina; Swerdloff, Ronald.

In: International Journal of Endocrinology, Vol. 2012, 625434, 2012.

Research output: Contribution to journalReview article

@article{4fd1109152ee44caa552e59511804301,
title = "Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy",
abstract = "Hypogonadism in older men is a syndrome characterized by low serum testosterone levels and clinical symptoms often seen in hypogonadal men of younger age. These symptoms include decreased libido, erectile dysfunction, decreased vitality, decreased muscle mass, increased adiposity, depressed mood, osteopenia, and osteoporosis. Hypogonadism is a common disorder in aging men with a significant percentage of men over 60 years of age having serum testosterone levels below the lower limits of young male adults. There are a variety of testosterone formulations available for treatment of hypogonadism. Data from many small studies indicate that testosterone therapy offers several potential benefits to older hypogonadal men. A large multicenter NIH supported double blind, placebo controlled study is ongoing, and this study should greatly enhance the information available on efficacy and side effects of treatment. While safety data is available across many age groups, there are still unresolved concerns associated with testosterone therapy. We have reviewed the diagnostic methods as well as benefits and risks of testosterone replacement therapy for hypogonadism in aging men.",
author = "Surampudi, {Prasanth N} and Christina Wang and Ronald Swerdloff",
year = "2012",
doi = "10.1155/2012/625434",
language = "English (US)",
volume = "2012",
journal = "International Journal of Endocrinology",
issn = "1687-8337",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy

AU - Surampudi, Prasanth N

AU - Wang, Christina

AU - Swerdloff, Ronald

PY - 2012

Y1 - 2012

N2 - Hypogonadism in older men is a syndrome characterized by low serum testosterone levels and clinical symptoms often seen in hypogonadal men of younger age. These symptoms include decreased libido, erectile dysfunction, decreased vitality, decreased muscle mass, increased adiposity, depressed mood, osteopenia, and osteoporosis. Hypogonadism is a common disorder in aging men with a significant percentage of men over 60 years of age having serum testosterone levels below the lower limits of young male adults. There are a variety of testosterone formulations available for treatment of hypogonadism. Data from many small studies indicate that testosterone therapy offers several potential benefits to older hypogonadal men. A large multicenter NIH supported double blind, placebo controlled study is ongoing, and this study should greatly enhance the information available on efficacy and side effects of treatment. While safety data is available across many age groups, there are still unresolved concerns associated with testosterone therapy. We have reviewed the diagnostic methods as well as benefits and risks of testosterone replacement therapy for hypogonadism in aging men.

AB - Hypogonadism in older men is a syndrome characterized by low serum testosterone levels and clinical symptoms often seen in hypogonadal men of younger age. These symptoms include decreased libido, erectile dysfunction, decreased vitality, decreased muscle mass, increased adiposity, depressed mood, osteopenia, and osteoporosis. Hypogonadism is a common disorder in aging men with a significant percentage of men over 60 years of age having serum testosterone levels below the lower limits of young male adults. There are a variety of testosterone formulations available for treatment of hypogonadism. Data from many small studies indicate that testosterone therapy offers several potential benefits to older hypogonadal men. A large multicenter NIH supported double blind, placebo controlled study is ongoing, and this study should greatly enhance the information available on efficacy and side effects of treatment. While safety data is available across many age groups, there are still unresolved concerns associated with testosterone therapy. We have reviewed the diagnostic methods as well as benefits and risks of testosterone replacement therapy for hypogonadism in aging men.

UR - http://www.scopus.com/inward/record.url?scp=84859749042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859749042&partnerID=8YFLogxK

U2 - 10.1155/2012/625434

DO - 10.1155/2012/625434

M3 - Review article

C2 - 22505891

AN - SCOPUS:84859749042

VL - 2012

JO - International Journal of Endocrinology

JF - International Journal of Endocrinology

SN - 1687-8337

M1 - 625434

ER -